508 related articles for article (PubMed ID: 32685027)
1. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
2. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.
Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z
J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721
[TBL] [Abstract][Full Text] [Related]
3. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy.
Yang L; Han D; Zhan Q; Li X; Shan P; Hu Y; Ding H; Wang Y; Zhang L; Zhang Y; Xue S; Zhao J; Hou X; Wang Y; Li P; Yuan X; Qi H
Theranostics; 2019; 9(25):7680-7696. PubMed ID: 31695794
[TBL] [Abstract][Full Text] [Related]
4. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
5. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy.
Gong C; Tian J; Wang Z; Gao Y; Wu X; Ding X; Qiang L; Li G; Han Z; Yuan Y; Gao S
J Nanobiotechnology; 2019 Sep; 17(1):93. PubMed ID: 31481080
[TBL] [Abstract][Full Text] [Related]
6. Tumor Microenvironment-Triggered Charge Reversal Polymetformin-Based Nanosystem Co-Delivered Doxorubicin and IL-12 Cytokine Gene for Chemo-Gene Combination Therapy on Metastatic Breast Cancer.
Sun Y; Liu L; Zhou L; Yu S; Lan Y; Liang Q; Liu J; Cao A; Liu Y
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45873-45890. PubMed ID: 32924511
[TBL] [Abstract][Full Text] [Related]
7. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy.
Wang J; Chen P; Dong Y; Xie H; Wang Y; Soto F; Ma P; Feng X; Du W; Liu BF
Biomaterials; 2021 Sep; 276():121056. PubMed ID: 34364178
[TBL] [Abstract][Full Text] [Related]
8. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
9. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.
Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723
[TBL] [Abstract][Full Text] [Related]
11. Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor.
Gong C; Zhang X; Shi M; Li F; Wang S; Wang Y; Wang Y; Wei W; Ma G
Adv Sci (Weinh); 2021 May; 8(10):2002787. PubMed ID: 34026432
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
[TBL] [Abstract][Full Text] [Related]
13. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
14. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.
Qi H; Liu C; Long L; Ren Y; Zhang S; Chang X; Qian X; Jia H; Zhao J; Sun J; Hou X; Yuan X; Kang C
ACS Nano; 2016 Mar; 10(3):3323-33. PubMed ID: 26938862
[TBL] [Abstract][Full Text] [Related]
15. Multi-antitumor therapy and synchronous imaging monitoring based on exosome.
Qian R; Jing B; Jiang D; Gai Y; Zhu Z; Huang X; Gao Y; Lan X; An R
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2668-2681. PubMed ID: 35091755
[TBL] [Abstract][Full Text] [Related]
16. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
[TBL] [Abstract][Full Text] [Related]
17. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy.
Kwon SH; Faruque HA; Kee H; Kim E; Park S
Colloids Surf B Biointerfaces; 2021 Sep; 205():111915. PubMed ID: 34130212
[TBL] [Abstract][Full Text] [Related]
19. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy.
Yong T; Zhang X; Bie N; Zhang H; Zhang X; Li F; Hakeem A; Hu J; Gan L; Santos HA; Yang X
Nat Commun; 2019 Aug; 10(1):3838. PubMed ID: 31444335
[TBL] [Abstract][Full Text] [Related]
20. ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy.
Wan Z; Gan X; Mei R; Du J; Fan W; Wei M; Yang G; Qin W; Zhu Z; Liu L
J Nanobiotechnology; 2022 Aug; 20(1):385. PubMed ID: 35999549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
